Ligand Pharmaceuticals (LGND)
(Delayed Data from NSDQ)
$70.37 USD
-0.63 (-0.89%)
Updated Apr 25, 2024 04:00 PM ET
After-Market: $70.32 -0.05 (-0.07%) 7:58 PM ET
1-Strong Buy of 5 1
D Value D Growth B Momentum D VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
05/07/2024
Time: AMC |
3/2024 | $1.13 | 0.00% |
Earnings Summary
For their last quarter, Ligand Pharmaceuticals (LGND) reported earnings of $1.05 per share, beating the Zacks Consensus Estimate of $0.58 per share. This reflects a positive earnings surprise of 81.03%. Look out for LGND's next earnings release on May 07, 2024. For the next earning release, we expect the company to report earnings of $1.13 per share, reflecting a year-over-year decrease of 50.44%.
Earnings History
Price & Consensus
Zacks News for LGND
Corcept (CORT) Posts Positive Data From Cushing's Syndrome Study
LGND: What are Zacks experts saying now?
Zacks Private Portfolio Services